课题基金 / 基金详情

VACCINE AND TREATMENT EVALUATION UNIT: Phase 4 Tuberculosis Therapeutics Trial

VACCINE AND TREATMENT EVALUATION UNIT: Phase 4 Tuberculosis Therapeutics Trial
疫苗和治疗评估单位:第 4 阶段结核病治疗试验
批准号:
9571682
负责人:
DANIEL HOFT
金额:
$21.92万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-03-07 至 2017-12-31

项目摘要

项目成果

DANIEL HOFT的其他基金

相似基金

相关文献

中文摘要
翻译
该计划由学术中心和组织内部的个人合同组成,为设计和进行临床试验提供现成的资源,以评估抗击传染病的有前途的产品。一般来说,产品将在正常健康人群中进行评估;然而,也可以接触到特殊人群。
英文摘要
This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vaccine and Treatment Evaluation Units: Clinical Operations Support
  • 批准号:
    10204823
  • 项目类别:
  • 资助金额:
    $17.5万
  • 财政年份:
    2019
  • 负责人:
    DANIEL HOFT
  • 依托单位:
Vaccine and Treatment Evaluation Units: Protocol Development and Implementation for a Natural History Challenge Study for Influenza
  • 批准号:
    9935238
  • 项目类别:
  • 资助金额:
    $96.18万
  • 财政年份:
    2019
  • 负责人:
    DANIEL HOFT
  • 依托单位:
Vaccine and Treatment Evaluation Units: Clinical Operations Support
  • 批准号:
    10674665
  • 项目类别:
  • 资助金额:
    $9.46万
  • 财政年份:
    2019
  • 负责人:
    DANIEL HOFT
  • 依托单位:
Vaccine and Treatment Evaluation Units: Clinical Operations Support
  • 批准号:
    10464970
  • 项目类别:
  • 资助金额:
    $17.69万
  • 财政年份:
    2019
  • 负责人:
    DANIEL HOFT
  • 依托单位:
海外基金